Posterior cortical atrophy

¹Division of Life Sciences (Neuroscience), University of Toronto, Scarborough College, Toronto, Ontario, Canada. zakazanis@utsc.utoronto.ca

|June 14, 2003

Summary

Posterior cortical atrophy (PCA) is a distinct dementia syndrome with early visual and cognitive deficits. Further research is needed to clarify PCA

Area of Science:

Background:

Posterior cortical atrophy (PCA) was first described in 1988.
PCA presents as a progressive dementia with similarities and distinctions to Alzheimer's disease.
Key features include early visual agnosia, Balint's syndrome, Gerstmann's syndrome, and transcortical sensory aphasia.

Purpose of the Study:

To review the history, epidemiology, pathophysiology, neurobehavioral aspects, assessment, differential diagnosis, and treatment of PCA.
To highlight the clinical homogeneity of PCA as originally defined.
To identify gaps in current understanding and research regarding PCA.

Main Methods:

Literature review encompassing historical data, epidemiological studies, and clinical case series.
Analysis of neurobehavioral and neurophysiologic findings in PCA.
Comparison of PCA with other neurodegenerative disorders like Alzheimer's disease, Pick's disease, and Creutzfeldt-Jakob disease.

Main Results:

PCA is characterized by a consistent cluster of symptoms, indicating clinical homogeneity.
While behavioral and cognitive aspects are established, epidemiology and treatment remain poorly understood.
Current understanding of PCA pathophysiology and treatment is largely extrapolated from studies on other neurodegenerative diseases.

Conclusions:

PCA presents as a clinically homogeneous syndrome with distinct visual and cognitive manifestations.
Significant gaps exist in the research concerning PCA epidemiology and effective treatment strategies.
Further research is crucial to definitively classify PCA and differentiate it from other neurodegenerative conditions.

Related Experiment Videos